n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride has been researched along with levodopa in 3 studies
| Studies (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Trials (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Recent Studies (post-2010) (n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 67 | 0 | 0 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, S; Starr, MS | 1 |
| Kaur, S; Starr, M | 1 |
| Brooks, S; Kaur, S; Starr, BS; Starr, MS | 1 |
3 other study(ies) available for n-n-propyl-n-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride and levodopa
| Article | Year |
|---|---|
Antiparkinsonian action of dextromethorphan in the reserpine-treated mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Behavior, Animal; Dextromethorphan; Dopamine Agonists; Drug Interactions; Levodopa; Locomotion; Male; Mice; Mice, Inbred Strains; Motor Activity; Parkinson Disease, Secondary; Phenethylamines; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine | 1995 |
Motor effects of lamotrigine in naive and dopamine-depleted mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Uptake Inhibitors; Animals; Anticonvulsants; Antiparkinson Agents; Benserazide; Depression, Chemical; Dopamine; Dopamine Agonists; Gait; Lamotrigine; Levodopa; Male; Mice; Mice, Inbred Strains; Motor Activity; Phenethylamines; Posture; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Triazines | 1996 |
Motor actions of eliprodil in the normal and monoamine-depleted mouse: a role in the treatment of Parkinson's disease?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Biogenic Monoamines; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Efferent Pathways; Excitatory Amino Acid Antagonists; Levodopa; Locomotion; Male; Mice; Mice, Inbred Strains; Motor Neurons; Parkinson Disease; Phenethylamines; Piperidines; Receptors, Dopamine D1; Reserpine; Sympatholytics | 1996 |